Change in apoB levels may be better predictor of clinical response than LDL-C, HDL-C levels
MRAs such as spironolactone and eplerenone are “still underused in routine clinical practice” but can be effective in countering the harms of high aldosterone levels, explained study author Professor Farzin Beygui, MD, PhD.
Researchers enrolled patients with ST-segment elevation myocardial infarction (STEMI) or non-STEMI (NSTEMI) who were undergoing PCI and receiving a potent P2Y12 inhibitor to receive bivalirudin or heparin during PCI.
In new study using insertable cardiac monitors, rate of AF detection was 40 percent at 30 months
The PRECISION-ABPM study included 444 patients (408 with osteoarthritis; 36 RA) who had evidence of, or were at increased risk for, coronary artery disease.
The primary safety endpoint was defined as time to major bleeding events and clinically relevant non-major bleeding events when compared to triple therapy with warfarin.
Primary outcome for fewer patients receiving rivaroxaban plus aspirin, but more major bleeding
150-mg dose met prespecified threshold for significance for primary and secondary end points
Want to read more?
Please login or register first to view this content.